Safety and Immunogenicity of IVX-A12 in Healthy Older Adults
Clinical trial NCT05664334 · COMPLETED
Trial details
- NCT number
- NCT05664334
- Sponsor
- Icosavax, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-21
- Primary completion
- 2024-01-24
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.